42 results on '"Sue, Carolyn M."'
Search Results
2. Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
3. Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting
4. NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactions
5. The pathogenesis of Parkinson's disease
6. Clinical drivers of hospitalisation in patients with mitochondrial diseases
7. Strong Predictive Algorithm of Pathogenesis-Based Biomarkers Improves Parkinson’s Disease Diagnosis
8. The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease
9. Single cell morphology distinguishes genotype and drug effect in Hereditary Spastic Paraplegia
10. Outcome measures for hereditary spastic paraplegia clinical trials: Learnings from an Australian HSP center
11. Pharmacological rescue of mitochondrial and neuronal defects in SPG7 hereditary spastic paraplegia patient neurons using high throughput assays
12. Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review
13. 2622 Refining a hereditary spastic paraplegia quality of life (HSPQoL) rating scale using consumer consultation
14. 14 Peripheral blood mononuclear cells from patients withSPASThereditary spastic paraplegia (HSP-SPAST) show disease-associated effect of reduced acetylated α-tubulin
15. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
16. Genetic Testing in Parkinson's Disease
17. Generation of human-induced pluripotent-stem-cell-derived cortical neurons for high-throughput imaging of neurite morphology and neuron maturation
18. Reduced acetylated α-tubulin in SPAST hereditary spastic paraplegia patient PBMCs
19. Low disease risk and penetrance in Leber hereditary optic neuropathy
20. Additional file 1 of NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactions
21. Additional file 1 of Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting
22. Towards the optimal care of Parkinson's disease: A guide for GPs.
23. Author Response: Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
24. PINK1 signalling in neurodegenerative disease
25. Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
26. The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies
27. Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
28. Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygousYARS2pathogenic variants
29. Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants
30. The commercial genetic testing landscape for Parkinson's disease
31. PINK1 signalling in neurodegenerative disease
32. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations
33. Cognitive Influences in Parkinson's Disease Patients and Their Caregivers: Perspectives From an Australian Cohort
34. NEMoE: A nutrition aware regularized mixture of experts model addressing diet-cohort heterogeneity of gut microbiota in Parkinson’s disease
35. The commercial genetic testing landscape for Parkinson's disease
36. Mitochondrial donation: is Australia ready?
37. Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variants.
38. Mitochondrial donation: is Australia ready?
39. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations.
40. Author Response: Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis.
41. International Genetic Testing and Counseling Practices for Parkinson's Disease.
42. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.